The Beat

About Maria Torroella Carney: Dr. Maria Torroella Carney is a highly respected internist, geriatrician, and palliative care physician with a robust background in public health. She is the Chief of the Division of Geriatric and Palliative Medicine at the Zucker School of Medicine and an Associate Professor of Medicine. She also holds the position of Chief of Geriatric and Palliative Medicine for Northwell Health. As the first geriatrician to serve as a health department commissioner in New York State, Dr. Carney has made significant contributions to the field of longevity promotion and the care of vulnerable populations. Her research focuses on advanced care planning, shared decision-making, elder abuse, and capacity assessment. She has received numerous awards for her outstanding community service and leadership.Things You’ll Learn:Hospice is a model of care focused on quality of life, not just end-of-life, and includes comprehensive support services. It's underutilized due to a lack of understanding and difficult decisions required regarding foregoing certain treatments.Patients should be able to explore hospice without feeling obligated to stop other care immediately.Family caregivers are an "invisible workforce" that requires more support, education, and resources. They are integral to the healthcare team yet often overlooked.Elder orphans, those aging without family support, are a growing concern and need early identification and tailored support.Geriatric medicine and palliative care are in their infancy and require more attention and specialists to meet their increasing needs. There's an insufficient number of professionals in these fields.Resources:Connect with and follow Maria Torroella Carney on LinkedIn.Discover more about Northwell Health on LinkedIn and their website.Buy Maria Torroella Carney’s The Aging Revolution here.

About Dr. Richard Milani: Dr. Milani serves as the Chief Clinical Innovation Officer, at Sutter Health.  His background and research focus on population health with a special interest in chronic disease, medical informatics, preventive medicine, and healthcare technology. After receiving his Internal Medicine training at the University of Florida, Dr. Milani completed fellowships in Critical Care Medicine at the University of Florida, Preventive Medicine, and Clinical Epidemiology at Harvard University (Massachusetts General Hospital), and Cardiovascular Diseases at Ochsner Clinic Foundation. He has authored over 500 medical publications, is on the editorial board for several medical journals, and serves as a frequent lecturer for healthcare systems and Fortune 500 companies as well as an advisor to venture capital firms and emerging healthcare technology companies. Things You’ll Learn:AI and scribe companies are being used to reduce clinician documentation time, and reduce 'pajama time'.AI models can predict patient deterioration, such as cardiac arrest, and allow for early intervention, reducing cardiac arrests by 44%.AI should act as an assistant, with a human clinician always in the loop for evaluation and decision-making.Technology should point clinicians toward patients most in need, optimizing care and resource allocation.Digital tools that can monitor the activities of daily living unobtrusively are the future of patient care, especially for elderly patients living alone.Resources:Connect with and follow Dr. Richard Milani on LinkedIn.Discover more about Sutter Health on LinkedIn and visit their website.

In this conversation, Dr. David Carmouche discusses the critical transition from fee-for-service to value-based care in the healthcare industry, emphasizing the role of AI in enhancing primary care and improving patient outcomes. He highlights the financial pressures on health systems and the importance of aligning incentives to achieve sustainability. The discussion also covers the innovative solutions offered by Lumeris and the transformative potential of AI in automating care processes and improving patient engagement. Finally, Dr. Carmouche addresses the need for regulatory guardrails as AI becomes more integrated into healthcare delivery.In this episode , they discuss:The shift from fee-for-service to value-based care is essential for financial sustainability.AI is poised to transform primary care delivery and patient engagement.Healthcare costs have been deemed unsustainable for decades, necessitating change.Aligning incentives is crucial for improving patient outcomes in healthcare.Lumeris has a decade-long history of partnering with health systems for value-based care.AI can automate and standardize care processes, enhancing efficiency.Data availability and interoperability are key to successful value-based care models.Generative AI can proactively engage patients and improve care delivery.Training clinicians to effectively use AI is vital for its successful integration.Regulatory guardrails will be necessary as AI becomes more prevalent in healthcare.A little about Dr David Carmouche: David Carmouche, MD, is the Executive Vice President & Chief Clinical Transformation Officer at Lumeris. Dr. Carmouche is a visionary leader in transformational healthcare delivery, with a unique blend of provider, payer, retail, and integrated delivery network leadership experience.Prior to joining Lumeris, Dr. Carmouche served as Walmart’s Senior Vice President of Healthcare Delivery, where he led the fleet of Walmart Health centers, Walmart Health Virtual Care, a value-based care partnership with Optum, and Walmart’s work to address Social Determinants of Health. Dr. Carmouche has also held significant leadership roles with Ochsner Health, the largest nonprofit academic healthcare system in the Gulf South, and Blue Cross Blue Shield of Louisiana, where he introduced the company’s first value-based care contracts. Earlier in his career, he built and led a multidisciplinary internal medicine and preventive cardiology practice.Dr. Carmouche attended Tulane University and LSU Medical School in New Orleans. Board-certified in Internal Medicine, he completed his residency at the University of Alabama at Birmingham, where he later served as Chief Resident. He serves as President of the Board of the Consortium for Southeastern Healthcare Quality and on the advisory board at Stellar Health. He has served on the board of the National Association of Accountable Care Organizations.

About Chris Moniz: Chris Moniz is a Managing Director at HSBC Holdings. Previously, he was a Managing Director and Market Manager at SVB Financial Group, leading Northwest & Northeast HealthTech & Medical Devices. A contributing author to HSBC Innovation Banking's 1H 2023 Venture Healthcare Report, Chris offers expertise and actionable insights to healthcare companies and investors.About Kristin Apple: Kristin Apple is President of LINUS, guiding leaders in health, wellness, and life sciences through transformative decisions. With 20+ years of experience advising major healthcare, pharmaceutical, and CPG companies, she's passionate about healthcare innovation. Previously, she led the healthcare vertical at Egg Strategy. Her background includes nearly six years at Eli Lilly, launching blockbuster drugs. Kristin holds an MBA from the University of Colorado and a degree from Indiana University.Things You’ll Learn:There is a growing concern among young physicians that patient trust is eroding, coupled with a mirroring lack of trust in patients.Young physicians are eager to incorporate AI into their practices for diagnosis and therapeutic decision-making while maintaining the human connection as an essential aspect of the patient-physician relationship.Technology should be used to enhance patient connection and streamline administrative tasks, not to replace human interaction.The future of healthcare involves a community-centric approach, with care delivered where people are, integrating their support systems.The healthcare industry must embrace and shape inevitable changes rather than be overtaken by them.Resources:Connect with and follow Chris Moniz on LinkedIn.Discover more about HSBC on LinkedIn and visit their website.Follow and connect with Kristin Apple on LinkedIn.Learn more about LINUS on their LinkedIn and website.Check out the Health 2035 Report here. 

Sandy and Craig discuss how Wellsheet achieves high clinician satisfaction, how it improves over time, and how it has earned the trust of hospitals across the country. Craig Limoli co-founded Wellsheet as a solution to the frustrations he noticed clinicians had with existing technologies, particularly around accessing patient data in a user-friendly format. Wellsheet’s patient summaries are preferred by 94% of clinicians for chart review, reducing chart review time by 50% and length of stay by 16.3%. Sandy and Craig also discuss Wellsheet’s recent partnership with UpToDate, allowing clinicians to access contextually relevant data faster. In this episode, they discuss:How Wellsheet contextualizes data to give clinicians the most relevant information to make treatment decisionsWellsheet’s impact on the inpatient side of healthcare, delivering ROI on clinician satisfaction and burnout while increasing productivityHow Wellsheet addresses workflow bottlenecks at hospitalsThe money hospitals are saving by implementing Wellsheet’s AI solution, which mainly comes from reducing the patient length-of-stays The breadth of adoption across healthcare systems that differentiates Wellsheet as an AI solutionDifferent use-cases for Wellsheet throughout healthcare practicesWellsheet’s partnership with UpToDate, allowing for integration and seamless workflows A little about Craig:Craig Limoli founded Wellsheet after seeing the frustration that clinicians faced with existing technologies while he worked at IBM in their Watson Health division. He left his MBA program at Wharton to found Wellsheet with a mission to create a better experience for physicians and care teams.Aligning his solutions with the problems clinicians identified, Craig built Wellsheet’s AI solution to help clinicians access relevant patient information in a contextualized, user-friendly format. In 2017, Craig brought Wellsheet to the market, primarily serving small practices. Since then, Wellsheet's AI solution has been deployed to hundreds of hospitals across some of the largest health systems in the country and has delivered vast improvements in clinician productivity and experience.

About Mark Gee:Mark Gee is the Chief Growth Officer at Medecision, driving the expansion of Aerial™, a cloud-based healthcare solution that improves health outcomes, reduces costs, and enhances engagement for value-based care organizations. With extensive experience in healthcare leadership, including roles at WellSky, Ciox/Datavant, and ERT, Gee has launched innovative care solutions and spearheaded data-driven strategies to optimize operations. Holding an M.S. in Instructional Design and Lean Systems Management, he excels in disruptive innovation and strategic growth, positioning Medecision as a leader in transforming healthcare delivery and operational efficiencies.Things You’ll Learn:Medecision's platform, Ariel, is designed to accept any data format and process it in real time, a crucial factor for unlocking potential use cases and overcoming the limitations of rigid systems. Traditional care management is failing because it focuses on the sickest 20% of patients, overlooking rising-risk individuals. Medecision's core goal is to deliver proactive care and act as a safety net for patients by identifying problems earlier. Many healthcare organizations have rigid data schemas that slow down implementations and limit the use of valuable data. Medecision created hyper-personalized care journeys with micro cohorts that adapt and learn from each individual's conditions. This approach allows the system to surface needs and provide appropriate resources in real time.Resources:Connect with and follow Mark Gee on LinkedIn.Follow Medecision on LinkedIn and visit their website.

In this episode, Sandy Vance is speaking with Dr. Rob Fraser, founding CEO and current Chief Scientific Officer (CSO) and President,  of Molecular You, a comprehensive AI-supported blood biomarker analysis platform. It empowers clinicians to harness the power of molecular medicine and artificial intelligence to maximize patient health outcomes. Molecular You uses AI tools to provide the most up-to-date and research-backed data to clinicians. Episode NotesMolecular You uses proteomics and metabolomics to measure and track over 250 biomarkers and generate risk profiles for more than 26 health conditions. By providing visibility into the underlying biochemical pathways that drive disease, clinicians can identify and treat dysfunction before it progresses to disease. In this conversation, Sandy Vance speaks with Dr. Rob Fraser about the potential of AI in disease identification and prevention; as well as its potential in extracting valuable research to provide doctors with detailed data. From comorbidity support to giving patients a more active role in their health, Molecular You is driving change in healthcare. In this episode, they discuss:How Molecular You identifies diseases at the earliest possible point to give patients access to early treatmentSuccessful use cases for Molecular You’s detection insightsHow Molecular You supports women with early breast cancer identificationThe research curation processes used by Molecular You, which use LLMs and automationThe patient benefits of Molecular You, and how it helps patients live longer and healthier livesFact-checking and cross-referencing systems Molecular You has created to verify LLM-extracted informationMolecular You delivers personalized lifestyle, diet, and supplement recommendations to support longevity, chronic disease management, and early disease prevention How Molecular You uses AI tools to make sense of the data extracted from blood samples, and how they plan to continue implementing AI as the technology improvesA little about Dr. Fraser:Rob was the founding CEO and is the current President and Chief Scientific Officer (CSO) of Molecular You Corporation. Backed by his expertise in molecular diagnostics, molecularly targeted drug discovery and development, biochemistry, and regulatory compliance, Rob Fraser drives the innovation behind Molecular You’s multi-biomarker analytics. At Molecular You, Rob Fraser implemented a method of measuring hundreds of biomarkers from a single blood sample. This allows Molecular You to provide practitioners with detailed insights on patients, from early diagnoses to comorbidity support to diet personalization. Molecular You contextualizes this data establishing an LLM model, incorporating the world’s leading scientific literature.

About Julie Ebert:Julie Betts Ebert is Managing Director of Silicon Valley Bank’s National Life Science & Healthcare team, supporting life science companies in the Mid-Atlantic and Southeast with banking services, debt financing, and strategic growth advice. Previously, she led SVB’s Strategic Advisory effort, managing client engagements and advisory projects. Julie’s prior experience includes 10 years at Greenhill & Co., advising on M&A and restructuring, and roles at Prudential Securities and J.P. Morgan. She holds an M.B.A. from Columbia Business School and a B.S. in finance from the University of Virginia.Things You’ll Learn:There's been an increase in the number of deals being made in the health tech space, signaling a positive shift in the market despite funding not growing as drastically as there's a slight uptick.A significant portion of health tech companies, roughly a third that have raised money, are integrating AI into their products or services, demonstrating the growing importance of AI in healthcare innovation. Silicon Valley Bank's reports aim to create transparency in the market. They give companies access to critical information about venture capital trends and investment patterns, helping to level the playing field for these companies.The 2024 Future of Healthtech report also shows that investors are becoming more pragmatic about valuations, with fewer up rounds and an increase in flat or down rounds or deals where the terms are not disclosed at all. By offering its insights, being creative in its financing, and supporting companies with the knowledge to help move their businesses forward, Silicon Valley Bank shows that it is a bold leader who is playing a crucial role in transforming the healthcare industry and fostering innovation.Resources:Connect with and follow Julie Ebert on LinkedIn.Follow Silicon Valley Bank on LinkedIn and visit their website.Read this year’s SVB’s Future of Healthtech report here.

About Frank Harvey:Frank Harvey is the CEO of Surescripts, a company aiming to we convene healthcare organizations nationwide to simplify how health intelligence is shared. Frank is an experienced chief executive and investor and has held numerous senior leadership roles during his more than 35-year career in the healthcare technology, pharmacy and pharmaceutical sectors. His leadership philosophy is to treat every person with respect, keep communication honest, and always have a bias for action. When Frank isn’t working, he and his wife support their local Boys & Girls Clubs. They are also passionate defenders of clean water, working with local organizations to address the significant issue of toxic algae in local rivers.Things You’ll Learn:Electronic prescribing has significantly reduced medication errors, administrative costs, and physician/pharmacist callbacks, with an estimated annual savings of $140 billion for the US healthcare system.Interoperability allows for better clinical decisions by making a comprehensive patient history accessible, improving health outcomes.The nation is facing a shortage of primary care providers, so pharmacists are in the perfect position to be integrated into the care team, making better medicine treatment and delivery. Surescripts is part of the Healthcare community and has partnerships with pharmacies, PBMs, EHRs, and health systems, all working together to improve the process of healthcare.Implementing real-time prescription benefits can reduce healthcare costs by helping physicians select more cost-effective treatment options.Resources:Connect with and follow Frank Harvey on LinkedIn.Follow Surescripts on LinkedIn and visit their website.

About Zane Burke:Zane Burke is the CEO of Quantum Health, where he leads efforts to revolutionize healthcare navigation through innovative solutions that combine technology with a human touch. With a background in both healthcare IT and executive leadership, Zane brings a wealth of experience to his role. Prior to joining Quantum Health, he served as CEO of Livongo Health, Inc., and as President of Cerner Corporation, where he drove significant advancements in healthcare technology. Zane is known for his commitment to improving healthcare delivery and making it more efficient and patient-centered. He holds both an undergraduate degree and an MBA from Kansas State University. Passionate about creating great healthcare experiences and addressing societal imbalances, Zane is a visionary leader dedicated to driving sustainable innovation in the healthcare industry.Things You’ll Learn:The integration of advanced technology with personalized human interaction significantly enhances healthcare experiences.Quantum Health's pharmacy navigation solution helps reduce pharmacy costs, especially for specialty medications, by providing cost-effective alternatives at the point of care.Streamlining healthcare processes makes them more efficient and less cumbersome for both patients and providers.Similar navigation solutions could be applied to other areas of healthcare, such as surgery and oncology, to improve outcomes and manage costs.Quantum Health's commitment to leveraging artificial intelligence creates seamless consumer experiences and drives down healthcare costs.Resources:Connect with and follow Zane Burke on LinkedIn and X.Follow Quantum Health on LinkedIn and visit their website.